SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...

PROCEPT BioRobotics SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing ...

PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.35 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.54 per share a year ago. These ...

Analysts' ratings for PROCEPT BioRobotics PRCT over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below provides a concise overview of recent ratings by ...

PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) – Investment analysts at William Blair decreased their Q1 2025 earnings per share (EPS) estimates for PROCEPT BioRobotics in a research note ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on PROCEPT BioRobotics (PRCT – Research Report), with a price target of $100.00. The company’s shares ...

PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, Marketbeat reports.

SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company”), a surgical robotics company focused on advancing patient care by developing ...

Procept Biorobotics Corp (PRCT) reported its fourth-quarter 2024 earnings, revealing a revenue of $68.24 million, surpassing the forecast of $66.83 million. Despite the revenue beat, the company ...

Good afternoon and welcome to PROCEPT BioRobotics Fourth Quarter and Year End 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. We will be facilitating a ...